117 related articles for article (PubMed ID: 31423168)
1. Profiling of prognostic alternative splicing in melanoma.
Ma FC; He RQ; Lin P; Zhong JC; Ma J; Yang H; Hu XH; Chen G
Oncol Lett; 2019 Aug; 18(2):1081-1088. PubMed ID: 31423168
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Zong Z; Li H; Yi C; Ying H; Zhu Z; Wang H
Front Oncol; 2018; 8():537. PubMed ID: 30524964
[No Abstract] [Full Text] [Related]
3. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
4. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.
Liang Y; Song J; He D; Xia Y; Wu Y; Yin X; Liu J
J Cell Physiol; 2019 Sep; 234(9):15836-15846. PubMed ID: 30740675
[TBL] [Abstract][Full Text] [Related]
6. Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Xie ZC; Wu HY; Ma FC; Dang YW; Peng ZG; Zhou HF; Chen G
Am J Transl Res; 2019; 11(7):4010-4028. PubMed ID: 31396315
[TBL] [Abstract][Full Text] [Related]
7. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
9. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
10. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
11. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
12. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
13. Systematic Profiling of Alternative Splicing Events in Ovarian Cancer.
Liu J; Lv D; Wang X; Wang R; Li X
Front Oncol; 2021; 11():622805. PubMed ID: 33763357
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
Huang ZG; He RQ; Mo ZN
Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
[TBL] [Abstract][Full Text] [Related]
16. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Oncol; 2020; 10():1257. PubMed ID: 32793502
[No Abstract] [Full Text] [Related]
17. Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma.
Yang C; Wu Q; Huang K; Wang X; Yu T; Liao X; Huang J; Zhu G; Gong Y; Han C; Su H; Qin W; Peng T
Front Oncol; 2019; 9():511. PubMed ID: 31275849
[TBL] [Abstract][Full Text] [Related]
18. Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis.
Chen X; Zhao C; Guo B; Zhao Z; Wang H; Fang Z
Front Oncol; 2019; 9():928. PubMed ID: 31608231
[TBL] [Abstract][Full Text] [Related]
19. Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme.
Zhang B; Wu Q; Cheng S; Li W
J Oncol; 2021; 2021():4664955. PubMed ID: 34326872
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.
Yu M; Hong W; Ruan S; Guan R; Tu L; Huang B; Hou B; Jian Z; Ma L; Jin H
Front Oncol; 2019; 9():773. PubMed ID: 31552163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
